User login
Intensive Eye Treatment
Niadyne, Incorporated, introduces the NIA24 Intensive Eye Treatment, a dual-phase, predosed, multiaction eye mask to reduce the look of fine lines, wrinkles, and dark circles. The treatment begins with the aesthetician combining the predosed treatment base with the activating powder just prior to use. Once combined, the activated components are applied around the eye area. The Intensive Eye Treatment contains Pro-Niacin to help stimulate skin barrier repair, improve cell turnover, and energize skin. Haloxyl tripeptide complex decreases the red and blue color of dark circles under the eyes and acts as an anti-inflammatory agent. Lumispheres skin brightener diminishes the appearance of fine lines. Other ingredients firm and tighten skin, while reducing undereye bags and puffiness. The Intensive Eye Treatment is a professional treatment that is available exclusively through physicians. For more information, visit www.nia24.com/professional-treatments/.
Kybella Injection
Kythera Biopharmaceuticals announces US Food and Drug Administration approval of Kybella (deoxycholic acid), also known as ATX-101, a nonsurgical treatment indicated for improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults. Kybella is administered by injections into the fat under the chin, which causes destruction of fat cells. Once destroyed, those cells cannot store or accumulate fat. Each in-office treatment session is typically 15 to 20 minutes, and up to 6 treatments may be administered. Many patients experience visible results in 2 to 4 treatments. Once the aesthetic response is achieved, re-treatment is not expected. Kybella physician training programs will be initiated in late summer. For more information, visit www.mykybella.com.
Sun Shield Broad Spectrum Matte Sunscreen Lotion
Obagi Medical Products, Inc, a division of Valeant Pharmaceuticals North America LLC, introduces the Sun Shield Broad Spectrum Matte SPF 50 Sunscreen Lotion. It combines UVB absorption and UVA protection with a completely sheer application. It contains 10.5% zinc oxide and 7.5% octinoxate. The Sun Shield Broad Spectrum Matte Sunscreen Lotion is ideal for use on all skin types and is physician dispensed. For more information, visit www.obagi.com.
If you would like your product included in Product News, please e-mail a press release to the Editorial Office at cutis@frontlinemedcom.com.
Intensive Eye Treatment
Niadyne, Incorporated, introduces the NIA24 Intensive Eye Treatment, a dual-phase, predosed, multiaction eye mask to reduce the look of fine lines, wrinkles, and dark circles. The treatment begins with the aesthetician combining the predosed treatment base with the activating powder just prior to use. Once combined, the activated components are applied around the eye area. The Intensive Eye Treatment contains Pro-Niacin to help stimulate skin barrier repair, improve cell turnover, and energize skin. Haloxyl tripeptide complex decreases the red and blue color of dark circles under the eyes and acts as an anti-inflammatory agent. Lumispheres skin brightener diminishes the appearance of fine lines. Other ingredients firm and tighten skin, while reducing undereye bags and puffiness. The Intensive Eye Treatment is a professional treatment that is available exclusively through physicians. For more information, visit www.nia24.com/professional-treatments/.
Kybella Injection
Kythera Biopharmaceuticals announces US Food and Drug Administration approval of Kybella (deoxycholic acid), also known as ATX-101, a nonsurgical treatment indicated for improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults. Kybella is administered by injections into the fat under the chin, which causes destruction of fat cells. Once destroyed, those cells cannot store or accumulate fat. Each in-office treatment session is typically 15 to 20 minutes, and up to 6 treatments may be administered. Many patients experience visible results in 2 to 4 treatments. Once the aesthetic response is achieved, re-treatment is not expected. Kybella physician training programs will be initiated in late summer. For more information, visit www.mykybella.com.
Sun Shield Broad Spectrum Matte Sunscreen Lotion
Obagi Medical Products, Inc, a division of Valeant Pharmaceuticals North America LLC, introduces the Sun Shield Broad Spectrum Matte SPF 50 Sunscreen Lotion. It combines UVB absorption and UVA protection with a completely sheer application. It contains 10.5% zinc oxide and 7.5% octinoxate. The Sun Shield Broad Spectrum Matte Sunscreen Lotion is ideal for use on all skin types and is physician dispensed. For more information, visit www.obagi.com.
If you would like your product included in Product News, please e-mail a press release to the Editorial Office at cutis@frontlinemedcom.com.
Intensive Eye Treatment
Niadyne, Incorporated, introduces the NIA24 Intensive Eye Treatment, a dual-phase, predosed, multiaction eye mask to reduce the look of fine lines, wrinkles, and dark circles. The treatment begins with the aesthetician combining the predosed treatment base with the activating powder just prior to use. Once combined, the activated components are applied around the eye area. The Intensive Eye Treatment contains Pro-Niacin to help stimulate skin barrier repair, improve cell turnover, and energize skin. Haloxyl tripeptide complex decreases the red and blue color of dark circles under the eyes and acts as an anti-inflammatory agent. Lumispheres skin brightener diminishes the appearance of fine lines. Other ingredients firm and tighten skin, while reducing undereye bags and puffiness. The Intensive Eye Treatment is a professional treatment that is available exclusively through physicians. For more information, visit www.nia24.com/professional-treatments/.
Kybella Injection
Kythera Biopharmaceuticals announces US Food and Drug Administration approval of Kybella (deoxycholic acid), also known as ATX-101, a nonsurgical treatment indicated for improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults. Kybella is administered by injections into the fat under the chin, which causes destruction of fat cells. Once destroyed, those cells cannot store or accumulate fat. Each in-office treatment session is typically 15 to 20 minutes, and up to 6 treatments may be administered. Many patients experience visible results in 2 to 4 treatments. Once the aesthetic response is achieved, re-treatment is not expected. Kybella physician training programs will be initiated in late summer. For more information, visit www.mykybella.com.
Sun Shield Broad Spectrum Matte Sunscreen Lotion
Obagi Medical Products, Inc, a division of Valeant Pharmaceuticals North America LLC, introduces the Sun Shield Broad Spectrum Matte SPF 50 Sunscreen Lotion. It combines UVB absorption and UVA protection with a completely sheer application. It contains 10.5% zinc oxide and 7.5% octinoxate. The Sun Shield Broad Spectrum Matte Sunscreen Lotion is ideal for use on all skin types and is physician dispensed. For more information, visit www.obagi.com.
If you would like your product included in Product News, please e-mail a press release to the Editorial Office at cutis@frontlinemedcom.com.
